Literature DB >> 31302382

Perioperative complications associated with minimally invasive surgery of oblique lumbar interbody fusions for degenerative lumbar diseases in 113 patients.

Chao Liu1, Jian Wang2, Yue Zhou1.   

Abstract

OBJECTIVES: To describe perioperative complications occurring during oblique lumbar interbody fusion (OLIF) assisted by a retractor system for degenerative lumbar diseases. PATIENTS AND METHODS: The perioperative complications in 113 cases series utilizing a minimally invasive approach were recorded and analyzed. One hundred thirteen patients who received OLIF for degenerative lumbar diseases between November 2014 and February 2017 at a single center were evaluated. The most frequent diagnosis was spondylolisthesis (59 cases, 52.2%), followed by lumbar instability (24 cases, 21.2%), adjacent segmental disease (12 cases, 10.6%), adult degenerative scoliosis (11 cases, 9.8%) and discogenic low back pain (7 cases, 6.2%). One hundred thirty-four levels were treated, 88.5% one-level, 4.4% two-level, and 7.1% three-level surgeries. The most fused level was L4-5 (94 levels, 70.2%), followed by L3-4 (31 levels, 23.1%), and L2-3 (9 levels, 6.7%).
RESULTS: All perioperative complications only included adverse events related to the OLIF procedure. The most observed complications were donor-site pain (24 cases, 21.2%), followed by vertebral endplate fracture (15 cases, 13.3%), thigh numbness/pain (12 cases, 10.6%), psoas/quadriceps weakness (5 cases, 4.4%), sympathetic nerve injury (2 case, 1.8%), paralytic ileus (one case, 0.9%), segmental artery injury (one case, 0.9%), intervertebral infection (one, 0.9%), and contralateral femoral nerve palsy (one, 0.9%). All complications, including postoperative ipsilateral or contralateral thigh paresthesia, pain, and psoas/quadriceps weakness, were observed when operating at L4-L5. The incidence of complications excluding donor-site pain was 24.8% (28/113 cases). The patients with donor-site pain, thigh numbness/pain, psoas/quadriceps weakness, sympathetic nerve injury and paralytic ileus recovered within two months following surgery. The patient with intervertebral infection recovered at 3 months after surgery. One case of contralateral femoral nerve palsy recovered completely with no residual sensory or motor deficit at 6 months.
CONCLUSIONS: OLIF performed using a retractor system is a validated option to treat a wide spectrum of degenerative lumbar diseases with few perioperative complications and a quick recovery. Judicious use of this technique at the L4/5 level is recommended. Close attention to detail during the procedure can minimize complications that may be associated with the learning curve.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Complications; Degenerative lumbar diseases; Minimally invasive surgery; Oblique lumbar interbody fusion

Year:  2019        PMID: 31302382     DOI: 10.1016/j.clineuro.2019.105381

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  4 in total

1.  Biomechanical effects of an oblique lumbar interbody fusion combined with posterior augmentation: a finite element analysis.

Authors:  Shengjia Huang; Shaoxiong Min; Suwei Wang; Anmin Jin
Journal:  BMC Musculoskelet Disord       Date:  2022-06-27       Impact factor: 2.562

2.  Vertical split fracture of the vertebral body following oblique lumbar interbody fusion: A case report.

Authors:  Jong-Hwan Hong; Moon-Soo Han; Jung-Kil Lee; Bong Ju Moon
Journal:  Medicine (Baltimore)       Date:  2022-05-27       Impact factor: 1.817

3.  Neurologic deficit due to vertebral body osteophytes after oblique lumbar interbody fusion: A case report.

Authors:  Tae-Kyu Lee; Jae-Young Kim; Moon-Soo Han; Jung-Kil Lee; Bong Ju Moon
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

4.  Oblique lateral interbody fusion combined with different internal fixations for the treatment of degenerative lumbar spine disease: a finite element analysis.

Authors:  Shuyi Zhang; Zhengpeng Liu; Chenshui Lu; Li Zhao; Chao Feng; Yahui Wang; Yilong Zhang
Journal:  BMC Musculoskelet Disord       Date:  2022-03-04       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.